A domestic study has demonstrated the effect of deoxycholic acid (DCA), the main component of fat-destroying injections, on ...

Semaglutide injections reversed some cases of MASH liver disease in clinical trials, reducing inflammation in 62.9% of ...

First-generation GLP-1 drugs have found to cut down the risk of obesity-related cancers by 41%, outperforming weight-loss ...

While some people can reduce their ... three to five injection sessions with an average of 4.5 sessions. Generally, Kybella treatments should be permanent. Kybella destroys the fat cells that ...

You’ve likely heard the hype around Ozempic and Wegovy – weight loss drugs that have taken the world by storm. These ...

Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world's first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1 ...

Caliway has completed the End-of-Phase 2 (EOP2) meeting with the U.S. FDA for CBL-514, the world's first investigational drug for large-area subcutaneous fat reduction developed under the 505(b)(1) ...

"The Agency agrees that the 'reduction of abdominal subcutaneous fat' as the proposed indication reinforces our confidence in CBL-514's differentiated value, and its potential to redefine ...